A photo of Jane Koo.

Jane Koo, MD

  • Physician, Bone Marrow Transplantation and Immune Deficiency
  • Instructor, UC Department of Pediatrics
I believe patient care is a joint effort. My decisions are made collaboratively with the patient and their family.

About

Biography

As a bone marrow transplant physician, I believe patient care is a joint effort. My decisions are made collaboratively with the patient and their family.

I became interested in bone marrow transplantation during my residency because of my experiences with bone marrow transplant patients. Being able to build long-term and durable relationships with patients and their families drew me to this field. I also was attracted to the various medical patients I would be caring for —those with both malignant to non-malignant diseases.

My research focuses on complications following hematopoietic stem cell transplant, such as lung-related injury and thrombotic microangiopathy. I’m also conducting research related to bone marrow failure patients and the difficulties they face.

In my free time, I enjoy hiking and exploring Cincinnati with my family.

MD: University of California, San Diego, La Jolla, CA, 2014.

Residency: Pediatrics, University of California San Francisco, San Francisco, CA, 2017.

Fellowship: Pediatric Hematology/Oncology, University of Colorado/Children's Hospital Colorado, Aurora, CO, 2020.

Fellowship: Pediatric Bone Marrow Transplant, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2021.

Interests

Pediatric bone marrow transplantation

Services and Specialties

Bone Marrow Transplantation

Interests

Bone marrow failure syndromes; complications following transplant

Research Areas

Bone Marrow Transplantation and Immune Deficiency

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Selected

Pediatric Metastatic Cardiac Angiosarcoma Successfully Treated With Multimodal Therapy: Case Report and Review of Literature. Koo, J; Knight-Perry, J; Galambos, C; Browne, LP; Cost, CR. Journal of Pediatric Hematology/Oncology. 2021; 43:e203-e206.

Selected

Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment. Koo, J; Hayashi, M; Verneris, MR; Lee-Sherick, AB. Frontiers in Oncology. 2020; 10.

Selected

Pediatric ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma elements: Clinical case series and review of the literature. Koo, J; Garrington, TP; Kerr, K; Treece, AL; Cost, CR. Pediatric Blood and Cancer. 2020; 67.

Selected

Autoimmune cytopenias following allogeneic hematopoietic stem cell transplant in pediatric patients: Response to therapy and late effects. Koo, J; Giller, RH; Quinones, R; McKinney, CM; Verneris, MR; Knight-Perry, J. Pediatric Blood and Cancer. 2020; 67.

Selected

Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors. Koo, J; Silverman, S; Nuechterlein, B; Keating, AK; Verneris, MR; Foreman, NK; Mulcahy Levy, JM. Bone Marrow Transplantation. 2019; 54:1605-1613.

Electroceuticals for peripheral nerve regeneration. Maeng, W; Tseng, WL; Li, S; Koo, J; Hsueh, Y. Biofabrication. 2022.

Non-Palladium-Catalyzed Approach to the Synthesis of (E)-3-(1,3-Diarylallylidene)Oxindoles. Koo, J; Kim, M; Shin, KJ; Seo, JH. Molecules. 2022; 27.

Evaluation of the Safety and Ochratoxin A Degradation Capacity of Pediococcus pentosaceus as a Dietary Probiotic with Molecular Docking Approach and Pharmacokinetic Toxicity Assessment. Park, S; Koo, J; Kim, B; Pushparaj, K; Malaisamy, A; Liu, W; Balasubramanian, B. International Journal of Molecular Sciences. 2022; 23.

Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem. Koo, J; Auletta, JJ; Hartley, DM; Huber, J; Jaglowski, S; Kapadia, M; Kusnier, K; Lehmann, L; Maakaron, J; Myers, KC; et al. Transplantation and cellular therapy. 2022.

Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?. Jodele, S; Dandoy, CE; Sabulski, A; Koo, J; Lane, A; Myers, KC; Wallace, G; Chima, RS; Teusink-Cross, A; Hirsch, R; et al. Transplantation and cellular therapy. 2022; 28:392.e1-392.e9.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey